30+ Global Experts Urge an End to E-Cigarette Stigma and a Focus on Harm Reduction

Recently, one of the most influential public health conferences on electronic cigarettes, the "2021 E-Cigarette Summit," was held in the United States. Over 30 experts discussed the latest evidence on harm reduction and smoking cessation related to electronic cigarettes, with many experts urging public health organizations to actively disseminate these research findings, immediately stop stigmatizing electronic cigarettes, and regain public trust.
  Image: Screenshot from the 2021 U.S. E-Cigarette Summit website
The theme of this summit was "Exploring the Impact of E-Cigarettes on Smoking Rates." Attendees included executives from the U.S. Food and Drug Administration (FDA) and renowned experts from various fields such as public health, medicine, tobacco control, and drug reform.

However, shortly after the conference began, experts expressed their dissatisfaction with the stigmatization of electronic cigarettes by public health organizations and the media, shifting the focus of the conference to "How to Regain Trust on the E-Cigarette Issue." Some experts suggested timely dissemination of accurate information about electronic cigarettes, while others stated that protecting youth and helping smokers quit should not conflict, and a "bridge" should be sought between the two.

What are the serious consequences of smokers reverting to traditional cigarettes and public health organizations losing credibility due to the stigmatization of electronic cigarettes? <\/strong>

Prof. Kenneth Warner, the honorary dean of the University of Michigan School of Public Health, was the first expert to speak at this summit. He believes that most U.S. policymakers, public health organizations, and the media focus on issues related to youth concerning electronic cigarettes, which is not wrong. However, exaggerating the dangers of electronic cigarettes for this reason is absolutely incorrect.

Numerous studies worldwide have confirmed the harm reduction and smoking cessation efficacy of electronic cigarettes. The internationally recognized medical organization Cochrane, known as the "gold standard" in the industry, has pointed out that electronic cigarettes have smoking cessation efficacy and are more effective than nicotine replacement therapies. At this summit, Jamie Hartmann-Boyce, a senior researcher from the Cochrane Tobacco Addiction Group, reiterated this conclusion.
  Image: Cochrane indicates that the effectiveness of using e-cigarettes for smoking cessation is better than that of nicotine replacement therapies.
"We see from scientific evidence that electronic cigarettes can assist smokers in quitting and have great potential in reducing smoking rates and even mortality rates," Prof. Kenneth Warner stated. "However, due to the stigmatization of electronic cigarettes, many in the public, including smokers, mistakenly believe that the dangers of electronic cigarettes are as great as those of traditional cigarettes. This has led to many concerning phenomena."

The most direct consequence is the rise in smoking rates in the U.S. Professor Abigail Friedman from Yale University School of Public Health pointed out that bans on e-cigarette flavors (such as fruit flavors) have led many smokers to revert to traditional cigarettes. "Data shows that after San Francisco implemented a ban on e-cigarette flavors, the local youth smoking rate doubled, which will significantly increase our future smoking cessation costs." Furthermore, the continuous dissemination of misinformation will cause public health organizations and the media to lose the basic trust of society.

"Establishing and maintaining public trust in public health organizations is a core element of a successful public health campaign. However, due to the distortion of truth by some public health organizations, public trust is declining," said Mike Cummings, a professor of psychiatry and behavioral sciences at the Medical University of South Carolina. His speech was titled "Are We Willing to Risk Losing Public Trust?"
  Image: Summary of Professor Mike Cummings' keynote speech.
Regaining Public Trust: Clarifying Rumors and Balancing Smokers' Needs is Key <\/strong>

During the summit's discussion on "Nicotine, Policy, and Regulation," Cliff Douglas, former vice president of tobacco control at the American Cancer Society, emphasized the need to find common ground between "harm reductionists" and "prohibitionists": "Protecting youth and supporting adult smokers in quitting can and must be achieved simultaneously. At the same time, we cannot ignore the demands of e-cigarette users."#p#分页标题#e#

Cliff Douglas's viewpoint was echoed by many experts. Ethan Nadelmann, founder of the Drug Policy Alliance and an internationally recognized drug policy expert, stated that public health organizations cannot solely focus on the "potential harms" of e-cigarettes while ignoring the voices of current smokers and consumers. Cheryl Healton, a professor at NYU's Global School of Public Health, directly pointed out that smokers have the right to choose harm reduction strategies that suit them and should seek "new social equity" for them.
  Image: Professor Cheryl Healton's keynote speech titled "Seeking New Social Equity for Smokers: Do They Have the Right to Reduce Harm?"
Several countries have officially supported the use of e-cigarettes as a smoking cessation tool. At this summit, Ann McNeill, a tobacco addiction expert from King's College London, detailed the UK's e-cigarette policy, stating that the UK Department of Public Health has included the promotion of e-cigarettes as part of its "2030 Smoke-Free Goal" strategy.

"The UK's support for e-cigarettes is backed by substantial scientific evidence. Public health organizations should focus on disseminating this harm reduction evidence, which is crucial," Ann McNeill stated. She noted that the UK Department of Public Health published a research report on e-cigarettes as early as 2015, indicating that e-cigarettes could reduce 95% of the harm associated with traditional cigarettes, with harmful chemical content being almost negligible.

"We also need to clarify some rumors to reduce public misunderstandings about e-cigarettes," said Matthew Holman, director of the FDA's Center for Tobacco Products. For instance, the rumor about "e-cigarette lung disease" ("popcorn lung") has been clarified by the CDC: the culprit is vitamin E acetate found in illegal THC products, and legitimate nicotine e-cigarettes do not contain this substance.

Image: The domestic e-cigarette brand RELX has also clarified the rumor of "e-cigarette lung disease" through official channels: "Popcorn lung is not lung turning into popcorn; it's all due to excessive and random additives!"

Matthew Holman also revealed that the FDA "will help adult smokers access e-cigarettes and switch to e-cigarettes." According to reports from foreign media Filter, if e-cigarette products pass the FDA's pre-market tobacco application (PMTA), they will remain on the market under the premise of being "beneficial to public health." This would mean that the U.S. government officially recognizes the harm reduction efficacy of e-cigarettes.